Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
49.37
-0.26 (-0.52%)
At close: Oct 30, 2026, 4:00 PM EDT
50.00
+0.63 (1.28%)
After-hours: Oct 30, 2026, 7:45 PM EDT

Axogen Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
266.93225.21187.34159.01138.58127.36
Revenue Growth
24.32%20.21%17.81%14.74%8.82%13.41%
Cost of Revenue
68.9257.8645.3637.1429.7822.93
Gross Profit
198167.35141.98121.87108.81104.43
Selling, General & Admin
174.38142.32117.5115.99112.89105.67
Research & Development
37.4332.8927.7727.3425.6324.18
Operating Expenses
211.81175.2145.26143.33138.52129.84
Operating Income
-13.81-7.85-3.29-21.46-29.71-25.42
Interest Expense
-2.41-7.7-8.21-2.84-0.62-1.36
Interest & Investment Income
3.341.171.141.490.570.09
Other Non Operating Income (Expenses)
-2.19-1.320.391.090.81-0.31
EBT Excluding Unusual Items
-15.07-15.7-9.96-21.72-28.95-26.99
Other Unusual Items
-16.85-----
Pretax Income
-31.92-15.7-9.96-21.72-28.95-26.99
Net Income
-31.92-15.7-9.96-21.72-28.95-26.99
Net Income to Common
-31.92-15.7-9.96-21.72-28.95-26.99
Net Income Growth
------
Shares Outstanding (Basic)
524644434241
Shares Outstanding (Diluted)
524644434241
Shares Change
12.44%4.05%3.22%1.89%2.11%3.12%
EPS (Basic)
-0.62-0.34-0.23-0.51-0.69-0.65
EPS (Diluted)
-0.62-0.34-0.23-0.51-0.69-0.65
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
22.04-2.931.43-19.59-36.14-41.22
Free Cash Flow Per Share
0.43-0.060.03-0.46-0.86-1.00
Gross Margin
74.18%74.31%75.79%76.64%78.52%81.99%
Operating Margin
-5.17%-3.48%-1.75%-13.50%-21.44%-19.96%
Profit Margin
-11.96%-6.97%-5.32%-13.66%-20.89%-21.19%
Free Cash Flow Margin
8.26%-1.30%0.77%-12.32%-26.08%-32.36%
EBITDA
-6.96-0.873.45-16.97-26.62-22.47
EBITDA Margin
-2.61%-0.39%1.84%-10.67%-19.20%-17.64%
D&A For EBITDA
6.846.986.734.493.092.95
EBIT
-13.81-7.85-3.29-21.46-29.71-25.42
EBIT Margin
-5.17%-3.48%-1.75%-13.50%-21.44%-19.96%
SEC Filings: 10-K · 10-Q